Absorption, Metabolism, Distribution and Excretion (ADME) and Absolute Bioavailability Assessment of Zongertinib in Healthy Male Volunteers

Authors

Philipp M. Roessner (ORCID: https://orcid.org/0000-0001-7061-5690)
Fabian Müller (ORCID: https://orcid.org/0000-0002-0483-0293)
Renger G. Tiessen
Behbood Sadrolhefazi (ORCID: https://orcid.org/0009-0004-3321-0642)
Ralf Laux
Sven Wind (ORCID: https://orcid.org/0009-0007-6926-8311)
Adam Auclair (ORCID: https://orcid.org/0000-0001-6507-237X)
Hlaing Maw (ORCID: https://orcid.org/0000-0002-4051-7958)
Guanfa Gan (ORCID: https://orcid.org/0009-0008-4482-4366)
Rolf Grempler (ORCID: https://orcid.org/0000-0002-9291-4947)
David Joseph
David Minich (ORCID: https://orcid.org/0009-0001-5847-0940)

Institutions

Boehringer Ingelheim (Germany) (DE)
University of Groningen (NL)
Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
Boehringer Ingelheim (United States) (US)

Publication Details

Journal: Clinical Drug Investigation
Published: 2025-12-05
DOI: https://doi.org/10.1007/s40261-025-01509-9
Primary Topic: Chemotherapy-induced organ toxicity mitigation
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Absorption, Metabolism, Distribution and Excretion (ADME) and Absolute Bioavailability Assessment of Zongertinib in Healthy Male Volunteers

Philipp M. Roessner, Fabian Müller, Renger G. Tiessen, Behbood Sadrolhefazi et al.

Dec 5, 2025

Clinical Drug Investigation

Chemotherapy-induced organ toxicity mitigation

article

Absorption, Metabolism, Distribution and Excretion (ADME) and Absolute Bioavailability Assessment of Zongertinib in Healthy Male Volunteers

Philipp M. Roessner, Fabian Müller, Renger G. Tiessen, Behbood Sadrolhefazi, Ralf Laux, Sven Wind, Adam Auclair, Hlaing Maw, Guanfa Gan, Rolf Grempler, David Joseph, David Minich

December 5, 2025article en

Abstract

No abstract available for this paper.

Clinical Drug InvestigationVol. 46(2)

Boehringer Ingelheim (Germany) (DE), University of Groningen (NL), Friedrich-Alexander-Universität Erlangen-Nürnberg (DE), Boehringer Ingelheim (United States) (US)

Openalex Percentile: Top 46%

Chemotherapy-induced organ toxicity mitigation

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Absorption, Metabolism, Distribution and Excretion (ADME) and Absolute Bioavailability Assessment of Zongertinib in Healthy Male Volunteers — Philipp M. Roessner, Fabian Müller, et al. · Clinical Drug Investigation (2025) | TGRS Research Map | TGRS